INTRODUCTION
The majority of intrinsic plasma membrane proteins are Nglycosylated ; however, the role of this modification has not been clearly established. N-glycosylation is a co-translational event and therefore affects the folding of membrane proteins. The luminal oligosaccharyl transferase transfers the (Glc) $ (Man) * (GlcNAc) # oligosaccharide from dolichol pyrophosphate to the side chain of an asparagine residue within the acceptor site Asn-Xaa-Ser\Thr [1] . After removal of a single terminal glucose, the oligosaccharide facilitates the interaction of some nascent chains with the chaperone protein calnexin in the endoplasmic reticulum [2, 3] . N-glycosylation enhances the level of cell-surface expression of membrane proteins like Band 3 ; however, it is not usually essential for functionality [4] .
A survey of polytopic membrane proteins revealed that the sites of N-glycosylation are localized to single extracytosolic (EC) loops that contain more than 30 residues [5] . For example, in the anion exchanger (AE) gene family, human erythrocyte Band 3 (AE-1) is N-glycosylated at Asn-642 within the fourth EC loop [6] [7] [8] . The mouse, rat and chicken proteins are also Nglycosylated on the same loop [8] . Interestingly, trout erythrocyte Band 3 is N-glycosylated on the preceding EC loop 3 (Z-loop) and does not contain an acceptor site in EC loop 4 [9] . AE-2 and AE-3, like trout Band 3, contain N-glycosylation sites in an enlarged EC loop 3, but none in EC loop 4 [8, 10] . For most proteins, N-glycosylation is restricted to single loops because all other EC loops are devoid of acceptor (Asn-Xaa-Ser\Thr) sites. A number of membrane proteins (e.g. Na + \H + exchanger) contain acceptor sites on multiple loops ; however, only one loop is Nglycosylated [5] . The restriction in N-glycosylation may be biosynthetic. For example, the oligosaccharyl transferase may only have access to a single loop and once this loop is bound to the enzyme subsequent loops are prevented from binding to the active site. In this paper, a series of Band 3 mutants were constructed that contained acceptor sites on one or two loops.
Abbreviations used : AE, anion exchanger, C 12 E 8 , octa(ethylene glycol) mono-n-dodecyl ether ; EC, extracytosolic. * To whom correspondence should be addressed.
by site-directed mutagenesis in EC loop 3, with or without retention of the endogenous site. In the second set of mutants, EC loop 4 was duplicated and inserted into EC loop 2, again with or without retention of the endogenous site. Cell-free translation experiments using reticulocyte lysates showed that microsomes were able to N-glycosylate multiple EC loops in these Band 3 mutants. The acceptor site in EC loop 3 was poorly Nglycosylated, probably due to the suboptimal size (25 residues) of this EC loop. The localization of N-glycosylation sites to single EC loops in multi-span membrane proteins is probably due to the absence of suitably positioned acceptor sites on multiple loops.
Microsomal membranes were found to be capable of N-glycosylating multiple loops in the Band 3 constructs when translated in a reticulocyte lysate.
EXPERIMENTAL Materials
The following is a list of products and, in parentheses, their suppliers : MEGAscript4 in itro transcription kit with T7 RNA polymerase, DNase I and the cap analogue m7GpppGp (Ambion), rabbit reticulocyte translation system, canine pancreatic microsomes and RNasin (Promega) 
Oligonucleotide-directed mutagenesis and duplication of EC loop 4
The endogenous N-glycosylation site in the membrane domain of Band 3 at Asn-642 was mutated to Asp in the TM1\14 construct [11] using an oligonucleotide corresponding to the sense strand of the cDNA coding 5h-CAAGGTGTCCGAC-TCCTCAGCCC-3h and the double-stranded mutagenesis system from Clontech (underlining denotes the mutated codon). A novel N-glycosylation site (Asn&&'-Val-Thr) was created at endogenous Asn-556 in EC loop 3 of the TM1\14 construct containing the (N642D) mutation using a sense oligonucleotide 5h-CTACA-ACGTGTCGATGGTGCCC-3h to mutate Leu-558 to Thr. The mutant containing two glycosylation sites was constructed by substituting a KpnI-NsiI fragment containing the novel thirdloop glycosylation site into wild-type TM1\14.
A unique XbaI cleavage site located in the Band 3 cDNA in a position corresponding to EC loop 2 was utilized to insert an additional N-glycosylation acceptor site derived from EC loop 4 into Band 3. Two oligonucleotide primers were used to synthesize a DNA segment by PCR (35 cycles at 94 mC, 1 min ; 53 mC, 2 min ; 72 mC, 3 min) corresponding to EC loop 4 with terminal XbaI sites. Primer 1 was a sense oligonucleotide, 5h-GCT TCTAGATACCTACACCCAGAAACTCTC-3h and primer 2 was an anti-sense oligonucleotide, 5h-GAGTCTAGAAACTC-GGAACGCAAGCCCAGT-3h. The underlining indicates the XbaI cleavage sites. PCR reactions were carried out using the wild-type AE-1 sequence and AE-1 containing the N642D mutation, after linearization with EcoRI. The two PCR products were each ligated into the unique XbaI site in full-length Band 3, which was then cut with NcoI and EcoRV to create two TM1\14 constructs containing the endogenous glycosylation site and the XbaI inserts. The two PCR products were also ligated directly into the TM1\14 construct containing the N642D mutation. The insert into EC loop 2 results in the addition of an extra 35 residues with the following amino acid sequence at the insertion site :
The resulting mutations and insertions were confirmed by dideoxynucleotide chain termination DNA sequencing [12] .
In vitro transcription and translation
Plasmid DNA (1 µg) was linearized with HindIII and transcribed with T7 RNA polymerase in the presence of m(GpppGp for 4 h at 37 mC using the Ambion in itro transcription kit according to the manufacturer's instructions. The DNA template was removed by digestion with 2 units of DNase I for 15 min at 37 mC. The RNA was extracted with phenol\chloroform (1 : 1, v\v), precipitated with 0.1 vol. of 5 M ammonium acetate and 1 vol. of isopropyl alcohol and then resuspended in diethyl pyrocarbonate-treated water containing 2 units\µl RNasin.
Translation in a rabbit reticulocyte lysate was performed according to the supplier, Promega. One-tenth (0.5-2 µg) of the RNA transcribed in itro was added to 50 µl of translation mixture and translation was allowed to continue for 2 h at 30 mC. The detergent C "# E ) (at 0.1 % final concentration) was included in the translation mixture to prevent aggregation of the translated protein. Translation was also carried out in the presence of microsomal membranes (7 units per 50 µl). [$&S]Methionine (at 1 µCi\µl) was included in all translation mixtures. The translation products were examined by SDS\gel electrophoresis [13] followed by fluorography. N-glycosylation of translation products was confirmed by solubilization of the microsomes with 0.1 % C "# E ) and digestion with endoglycosidase H.
RESULTS
Band 3 is a suitable protein with which to test the hypothesis that N-glycosylation of single EC loops is due to a biosynthetic restriction. Band 3 (AE-1) contains a single site of Nglycosylation at Asn-642 in EC loop 4, but other family members (trout Band 3, AE-2 and AE-3) contain N-glycosylation sites in EC loop 3. N-glycosylation of EC loop 3 therefore does not impair the folding or function of anion exchangers. EC loop 3 in AE-1 is sensitive to external chymotrypsin cleavage in intact red blood cells [14] , which is consistent with its extracellular disposition. A point mutation was therefore made in human Band 3 to create a novel N-glycosylation site in EC loop 3. The endogenous site in EC loop 4 was either retained or destroyed (N642D) by site-directed mutagenesis. A cell-free system consisting of a reticulocyte lysate supplemented with microsomal membranes was used to assay the glycosylation status of the mutants. Microsomal membranes can N-glycosylate membrane proteins by the en bloc transfer of a (Glc) $ (Man) * (GlcNAc) # oligosaccharide from the dolichol pyrophosphate donor to a luminal acceptor site (Asn-Xaa-Ser\Thr) within the nascent polypeptide. This greatly simplifies the interpretation of the biosynthetic experiments, since N-glycosylation at a single site will produce a uniform increase of about 2500 in the molecular mass of the protein. This increase corresponds to the cotranslational attachment of the high-mannose oligosaccharide. A truncated construct (TM1\14) was used in the present experiments to improve the yield of full-length translation product and to better visualize the difference in molecular mass due to N-glycosylation [11] . Expression of the TM1\14 construct produces the 55 kDa C-terminal membrane domain of Band 3. This domain of human Band 3 is fully functional with respect to anion transport [15] . Figure 1 shows that the endogenous site at Asn-642 in the membrane domain of Band 3 can be efficiently N-glycosylated by microsomal membranes in the reticulocyte translation system (Figure 1, lanes 1 and 2) . A densitometric scan of lane 2 showed that the level of N-glycosylation in this experiment was 71 %. molecular mass when translation was carried out in the presence of microsomes (Figure 1, lanes 3 and 4) , confirming that the increase in molecular mass seen in lane 2 was due to Nglycosylation at Asn-642. A construct containing the mutated endogenous acceptor site and a novel site (Asn-556) in EC loop 3 can be glycosylated, but at 15 % efficiency (Figure 1 , lanes 5 and 6). This low efficiency may be due to the suboptimal size of EC loop 3, which contains 25 residues. The construct containing two acceptors sites on EC loops 3 and 4 was doubly glycosylated, but again at low efficiency (Figure 1, lanes 7 and 8) .
Mutation of Asn-642 to Asp did not result in any shift in

Figure 2 Folding model of the membrane domain of Band 3 (upper panel) and autoradiograph of [ 35 S]methionine-labelled cell-free translation products (lower panel) as in Figure 1
EC loop 4 contains an excellent acceptor site at Asn-642, therefore a set of mutant Band 3 constructs were made in which the entire EC loop 4 was duplicated and inserted into EC loop 2. The DNA encoding EC loop 2 contains a unique XbaI site which provided a convenient point for insertion of the DNA encoding EC loop 4. Figure 2 (lanes 1 and 2) shows that insertion into loop 2 of a mutated loop 4 that did not contain an acceptor site did not prevent N-glycosylation of the endogenous site in EC loop 4. This shows that insertion of the loop did not alter the topology of distal transmembrane segments in Band 3. The efficiency of N-glycosylation of the endogenous site in this experiment was 50 %. As expected, a construct containing a mutated Asn-642 that destroyed the endogenous site in the loop 4 insertion was not N-glycosylated (Figure 2, lanes 3 and 4) . A construct containing a mutated endogenous site with an acceptor site located in the EC loop 2 insertion was, however, as efficiently glycosylated (53 %) as the endogenous site (Figure 2, lanes 5 and   6) . The construct containing two acceptor sites, one in the loop 2 insert and the other the endogenous site in EC loop 4, was glycosylated on both loops (Figure 2, lanes 7 and 8) . The major cell-free translation product obtained was the double Nglycosylated protein (double closed arrowheads). The slower mobility of the cell-free translation products made in the presence of microsomes is due to N-glycosylation, since treatment of the translation products with endoglycosidase H after solubilization resulted in an increased mobility of the deglycosylated products (results not shown). The experiments in Figures 1 and 2 clearly show that N-glycosylation of multiple EC loops can occur in a cell-free system in the presence of microsomal membranes. The efficiency of N-glycosylation was dependent upon the size of the loops.
DISCUSSION
The vast majority of polytopic membrane proteins contain acceptor sites for N-glycosylation on single EC loops [5] . In proteins that contain acceptor sites on multiple loops only one loop is N-glycosylated. Inspection of the non-glycosylated loops in these membrane proteins revealed that they are either small or contain acceptor sites located close to a transmembrane segment. EC loops containing utilized N-glycosylation acceptor sites in multi-span membrane proteins have a minimum size of about 30 residues, with the N-glycosylation site at least 10 residues away from a transmembrane segment [5] . Cell-free translation experiments have shown that acceptor sites within the endoplasmic reticulum lumen must be spaced more than 12 residues C-terminal or more than 14 residues N-terminal from a transmembrane segment to be efficiently N-glycosylated [16] . In constructs containing poly(Leu) transmembrane segments it was found that the minimal glycosylation distance C-terminal to the transmembrane segment was 10 residues for a 23-residue transmembrane segment and 13 for hydrophobic segments shorter than 17 residues [17] . These results suggest that loops must have a minimum size of 25 residues to be N-glycosylated with the acceptor asparagine well-spaced from the ends of the adjoining transmembrane segments.
EC loop 4 in Band 3 contains about 35 residues and the glycosylation site is spaced 18 residues C-terminal from transmembrane segment 7, and 17 residues N-terminal to the beginning of transmembrane segment 8. This site is efficiently Nglycosylated. EC loop 3 in human AE-1 is smaller, containing about 25 residues, and an N-glycosylation acceptor site engineered into the middle of this loop was poorly Nglycosylated. The N-glycosylated EC loop 3 in trout Band 3 and in AE-2 and AE-3 contains a poorly conserved insert (Z-loop) doubling the size of the loop to about 50 residues. One reason for the enlarged size of this loop in these isoforms relative to most AE-1 gene products might be to allow efficient N-glycosylation. The poor N-glycosylation observed for the point mutation in EC loop 3 is probably due to the small size of the loop, which may restrict access of the loop to the active site of the oligosaccharyl transferase.
Insertion of EC loop 4 into EC loop 2 permitted efficient Nglycosylation of the acceptor site. The ability to N-glycosylate the insert in EC loop 2 provides evidence that this region of Band 3 is exposed to the endoplasmic reticulum lumen, which is in agreement with most folding models of Band 3 [8, [18] [19] [20] . This topology is not in agreement with the recent work of Kalo [21] , however, who concluded that this region of Band 3 is cytosolic on the basis of the radio-iodination of Tyr-486 by lactoperoxidase in inside-out vesicles. Unfortunately, the level of radio-iodination observed in this study was very low and a labelled peptide corresponding to the predicted "#&I-Y%)'IVGR sequence could not be isolated. Further studies of the topology of Band 3 are clearly required to resolve this issue.
The results presented in this paper show that microsomes can efficiently N-glycosylate multiple loops in Band 3, provided the loops are large enough. Evidence has been presented that chimaeric proteins [22, 23] can be N-glycosylated on multiple loops. These chimaeras consisted of truncated proteins fused to passenger domains that contained consensus glycosylation sites. The fact that suitable N-glycosylation acceptor sites are conspicuously absent from multiple loops in polytopic membrane proteins suggests that such sites may be detrimental. Such additional sites of N-glycosylation may interfere with folding, chaperone action or protein function. It has been found that novel glycosylation sites on alternate loops can sometimes be substituted for endogenous sites in membrane proteins without loss of activity [24, 25] . The presence of an N-linked carbohydrate on a novel loop therefore does not necessarily impair protein biosynthesis or function. In the AE gene family, oligosaccharide can be attached to either EC loop 3 or 4 without impairment of function. Perhaps all EC loops of sufficient size are threaded through the oligosaccharyl transferase upon exit of the nascent chain from the translocation channel. In this way, the oligosaccharyl transferase scans all luminal sequences for suitable acceptor sites. The presence of N-linked oligosaccharide on multiple loops may slow exit of the glycoprotein from the endoplasmic reticulum due to enhanced interaction with the oligosaccharyl transferase, calnexin or other processing enzymes. Increasing the number of cell-surface oligosaccharides on multiple loops may impair substrate access to transporters, channels and receptors. While N-glycosylation plays a role in the folding of membrane proteins and their subsequent exit from the endoplasmic reticulum, one glycosylation site is sufficient for this task and multiple glycosylated loops would entail an additional expenditure of energy that is not required. 
